Recruiting
Phase 2

DFMO & Etoposide

Sponsor:

Giselle Sholler

Code:

NCT04301843

Conditions

Neuroblastoma

Eligibility Criteria

Sex: All

Age: 0 - 31

Healthy Volunteers: Not accepted

Interventions

Eflornithine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Giselle Sholler on 2024-08-06.